Trial of Taselisib in Overgrowth
Clinical trial NCT03290092 · TERMINATED
Trial details
- NCT number
- NCT03290092
- Sponsor
- Centre Hospitalier Universitaire Dijon
- Status
- TERMINATED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-07-31
- Primary completion
- 2019-02-14
- Enrollment
- 19
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.